Cargando…
Correction: Reducing the harms of xylazine: clinical approaches, research deficits, and public health context
Autores principales: | Zagorski, Claire M., Hosey, Rebecca A., Moraff, Christopher, Ferguson, Aaron, Figgatt, Mary, Aronowitz, Shoshana, Stahl, Natalie E., Hill, Lucas G., McElligott, Zoe, Dasgupta, Nabarun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683201/ https://www.ncbi.nlm.nih.gov/pubmed/38012764 http://dx.doi.org/10.1186/s12954-023-00903-w |
Ejemplares similares
-
Reducing the harms of xylazine: clinical approaches, research deficits, and public health context
por: Zagorski, Claire M., et al.
Publicado: (2023) -
Invited Commentary: Drug Checking for Novel Insights Into the Unregulated Drug Supply
por: Dasgupta, Nabarun, et al.
Publicado: (2021) -
Considering the harms of our habits: The reflexive urine drug screen in opioid use disorder treatment
por: Khatri, Utsha G., et al.
Publicado: (2021) -
Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review
por: Zhu, David T.
Publicado: (2023) -
Goats Follow Human Pointing Gestures in an Object Choice Task
por: Nawroth, Christian, et al.
Publicado: (2020)